Abstract
Treatment of gram-negative infections has become increasingly complicated by the emergence of carbapenem-resistant (CR) Enterobacterales, Pseudomonas aeruginosa (Pa) and Acinetobacter baumannii. Despite their clinical and economic impact, there is a lack of robust national data in Brazil. Our objective was to determine the frequency of Enterobacterales and Pa in Brazil from 2018-2020.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have